期刊文献+

冠状动脉支架辐射灭菌后血液相容性和致畸毒性评价 被引量:3

Study on the blood compatibility and teratogenicity after radiation sterilization of the coronary artery stents
下载PDF
导出
摘要 聚酯聚乙烯复合膜/聚乙烯(冠脉支架系统)是一种新型医用高分子生物材料,应用于临床,为心肌血运重建的主要手段。本研究按照ISO111737标准对其进行了辐照灭菌的剂量设定。依据ISO10993标准对辐照灭菌后的产品,进行了血小板黏附性能、Ames和微核试验。结果显示,辐照灭菌后的聚酯聚乙烯复合膜/聚乙烯(冠状动脉支架系统)无遗传毒性(不会引起染色体畸变);无诱导骨髓多染红细胞微核发生率增高以及无致癌作用。辐照灭菌不影响聚酯聚乙烯复合膜/聚乙烯(冠状动脉支架系统)的稳定性,辐照后的产品未发生毒性作用,生物相容性良好,辐射灭菌作为医用高分子生物材料灭菌方法值得推广应用。 As polyester polyethylene composite membrane/polyethylene is a new type of biological material suitable for clinical uses, the products were conducted dosage setting for radiation sterilization in accordance with ISO111737 in order to certificate if they are safe after radiation sterilization by use of platelet adhesion performance test, Ames test and the mieronucleus test referred to ISO10993. It has been confirmed that after radiation sterilization the material have no genetic toxicity (not cause chromosomal aberrations) and can not increase the incidence of the micronucleus of the bone marrow polychromatocytes cells though there is no carcinogenic effects. Radiation sterilization does not affect the stability of the polyester polyethylene composite membrane/polyethylene (coronary artery stents). It means that as a good method radiation sterilization is worth to promote.
出处 《辐射研究与辐射工艺学报》 CAS CSCD 北大核心 2008年第5期289-294,共6页 Journal of Radiation Research and Radiation Processing
关键词 血液相容性 辐射灭菌 致畸毒性冠状动脉支架 Hemocompatibility, Radiation sterilization, Eratogenicity toxicity, Coronary stent
  • 相关文献

参考文献7

二级参考文献62

  • 1Kim YH, Han DK, Park KD, et al. Enhanced blood compatibility of polymers grafted by sulfonated PEO via a negative cilia concept. Biomaterials, 2003, 24:2213 -2223
  • 2Mao C, Zhu AP, Qiu YZ, et al. Introduction of Obutyrylchitosan with a photosensitive hetero-bifunctional crosslinking reagent to silicone rubber film by radiation grafting and its blood compatibility. Colloids and Surfaces B: Biointerfaces , 2003, 30:299-
  • 3Setsuko Y , Yuri S , Ken S , et al. Ion-sensor property and blood compatibility of neutral-carriertype poly (vinyl chloride ) membranes coated by phosphorylcholine polymers. Analytica Chimica Acta, 2002, 463: 31-37
  • 4Morimoto N, Iwasaki Y, Nakabayashi N, et al.Physical properties and blood compatibility of surface-modified segmented polyurethane by semi-interpenetrating polymer networks with a phospholipid polymer. Biomaterials, 2002, 23:4881-4887
  • 5Kim YJ, Kang IK, Huh MW, et al. Surface characterization and in vitro blood compatibility of poly (ethylene terephthalate) immobilized with insulin and/or heparin using plasma glow discharge. Biomaterials, 2000, 21:121-130
  • 6Kicheva YI, Kostov VD, Chichovska M. In vitro and in vivo studies of the effect of the concentration of plasticizer di (2-ethylhexyl) phthalate on the blood complitibility of plasticized poly (vinyl choride) drain tubes. Biomaterials, 1995, 16: 575-579
  • 7Wang XH, Zhang F, Li CR, et al. Improvement of blood compatibility of artificial heart valves via titanium oxide film coated on low temperature isotropic carbon. Surface and Coatings Technology, 2000, 128-129:36-42
  • 8Michael VS, Cynthia HG, Maud BG. What really is blood compatibility. J. Biomater. Sci. Polymer Edn., 2000, 11(11): 1165-1182
  • 9Li YJ, Yokawa T, Matthews KH, et al. Synthesis and blood compatibility evaluation of segmented polyurethanes based on cholesterol and phosphatidylcholine analogous moieties. Biomaterials, 1996, 17:2179-2189
  • 10Nho YC, Kwon OH, Chen J. Introduction of phosphoric acid group to polypropylene film by radiation grafting and its blood compatibility. Radiation Physics and Chemistry, 2002, 64: 67-75

共引文献38

同被引文献22

  • 1ISO 11737-1:Sterilization of medical devices-microbiologicalmedthods-part1:Estimation of population of microorganisms onproduct[S].2006:5-16.
  • 2ISO11137-2:Sterilization of health care products,Part2:Es-tablishing the sterilization dose[S].2006:5-14.
  • 3ISO10993-5.Biological evaluation of medical devices-part5:Tests for cytotoxicity:In vitro methods[S].2009E:24-28.
  • 4ISO10993-10.Biological evaluation of medical devices-part10:Tests for irritation and sensitization[S].2006:5-15.
  • 5ISO10993-3.Biological evaluation of medical devices-part3:Tests for Genotoxicity[S].2003:3-4.
  • 6Gov Y,Bitler A,Dell'Acqua G,et al.RNAIII inhibiting peptide(RIP),a global inhibitor of Staphylococcus aureus pathogenesis:structure and function analysis[J].Peptides,2001,22(10):1609.
  • 7Charles JM, David RH, Robert SS. Novel stents for theprevention of pestenosis[J]. TCM,1997, 7(7):245-246.
  • 8IS010993-5. Biological evaluation of medical devices-part5:Tests for cytotoxicity: In vitro methods[S]. 2009E:24-28.
  • 9IS010993-10. Biological evaluation of medical devices-part1O:Tests for irritation and sensitization[S], 2006:05-15.
  • 10IS010993-3. Biological evaluation of medical devices-part3:Tests for Genotoxicity[S].2003: 3-4.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部